▼ -100.00% Downside Potential
This price target is based on 4 analysts offering 12 month price targets for Tecan Group in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $480.00.
The current consensus among 4 contributing investment analysts is to buy stock in Tecan Group.
Tecan Group AG is a holding company, which engages in the development, production, and distribution of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. It operates through the following segments: Life Sciences Business, Partnering Business, and Corporate. The Life Sciences Business segment supplies end users with automated workflow solutions, which includes laboratory instruments, software packages, application know-how, services, consumables, and spare parts. The Partnering Business segment develops and manufactures original equipment manufacturer instruments and components. The company was founded by Heinz Abplanalp, Heini Maurer, Heini Moeckli, and Gallus Blatter on March 18, 1980 and is headquartered in Mannedorf, Switzerland.